R&D John Soloninka, President & CEO of HTX, talks about his vast experience in the pharmaceutical and healthcare sector, why he feels there is much room for growth in Canada still, and his strategy for the company’s international exposure. How did you come to lead HTX and what are the parallels…
See our Cookie Privacy Policy Here